Neuro-oncology
Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testing.
Neuro-oncology
EXTH-71. HYPERPOLARIZED [1-13C] PYRUVATE AS A BIOMARKER FOR TREATMENT MONITORING IN LYMPHOMA MURINE MODELS.
Neuro-oncology
Canine spontaneous glioma: a translational model system for convection-enhanced delivery.
Neuro-oncology
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.
Neuro-oncology
IMMU-52. SELECTION OF GLIOMA T-CELL THERAPY TARGETS BASED ON THE ANALYSIS OF TUMOR IMMUNOPEPTIDOME AND EXPRESSION PROFILES.
Neuro-oncology
Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide.
Neuro-oncology